News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
504,073 Results
Type
Article (10153)
Company Profile (176)
Press Release (493743)
Multimedia
Podcasts (21)
Webinars (7)
Section
Business (171578)
Career Advice (366)
Deals (26401)
Drug Delivery (21)
Drug Development (54402)
Employer Resources (22)
FDA (9949)
Job Trends (8977)
News (244500)
Policy (18368)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (13)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (617)
Accelerated approval (31)
ADA (21)
Adcomms (1)
Allergies (112)
Alliances (34527)
ALS (131)
Alzheimer's disease (1093)
Antibody-drug conjugate (ADC) (383)
Approvals (10681)
Artificial intelligence (439)
ASCO (167)
Autoimmune disease (294)
Automation (40)
Bankruptcy (272)
Belgium (6)
Best Places to Work (7153)
BIO (41)
Biologics (73)
BIOSECURE Act (3)
Biosimilars (149)
BioSpace Insights (35)
Biotechnology (101)
Bispecific (37)
Bladder cancer (155)
Brain cancer (43)
Breast cancer (573)
Cancer (4402)
Cardiovascular disease (273)
Career advice (300)
Career pathing (2)
CAR-T (215)
CDC (4)
CDMO (55)
Celiac Disease (6)
Cell-line development (1)
Cell therapy (597)
Cervical cancer (45)
Clinical research (49865)
Collaboration (1554)
Commercialization (37)
Company closure (4)
Compensation (1698)
Complete response letters (39)
COVID-19 (919)
CRISPR (84)
CRO (3)
C-suite (977)
Cystic fibrosis (94)
Data (7046)
Denatured (10)
Depression (117)
Dermatology (111)
Diabetes (410)
Diagnostics (4452)
Digital health (45)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (223)
Drug pricing (16)
Drug shortages (3)
Duchenne muscular dystrophy (200)
Earnings (75288)
Editorial (7)
Employer branding (3)
Employer resources (20)
ESMO (260)
Events (91159)
Executive appointments (805)
Eye disease (12)
FDA (13025)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (26)
Funding (1180)
Gene editing (161)
Generative AI (18)
Gene therapy (421)
GLP-1 (387)
Government (1074)
Grass and pollen (2)
Guidances (292)
Healthcare (9700)
Hematology (121)
HIV (63)
Huntington's disease (33)
Idiopathic pulmonary fibrosis (7)
IgA nephropathy (87)
Immunology and inflammation (162)
Immuno-oncology (94)
Indications (195)
Infectious disease (1148)
Inflammatory bowel disease (157)
Inflation Reduction Act (8)
Influenza (95)
Intellectual property (291)
Interviews (46)
IPO (12615)
IRA (7)
Job creations (2143)
Job search strategy (284)
JPM (5)
Kidney cancer (23)
Kidney disease (98)
Labor market (18)
Layoffs (113)
Leadership (4)
Legal (5282)
Licensing (84)
Liver cancer (54)
Longevity (31)
Lung cancer (622)
Lung diease (11)
Lymphoma (296)
Machine learning (35)
Management (7)
Manufacturing (725)
Marketing (27)
MASH (136)
Medical affairs (2)
Medical device (8838)
Medtech (9044)
Melanoma (26)
Mergers & acquisitions (14957)
Metabolic disorders (862)
Middle East (2)
mRNA (103)
Multiple sclerosis (125)
Multispecific (6)
NASH (4)
Netherlands (6)
Neurodegenerative disease (281)
Neuropsychiatric disorders (54)
Neuroscience (2165)
Neurotech (2)
NextGen: Class of 2026 (3353)
Non-profit (968)
Now hiring (21)
Obesity (284)
Opinion (32)
Ovarian cancer (193)
Pain (206)
Pancreatic cancer (261)
Parkinson's disease (239)
Partnered (17)
Patents (558)
Patient advocacy (4)
Patient recruitment (575)
Patient selection (71)
Peanut (36)
People (43328)
Peptides (26)
Pharmaceutical (31)
Pharmacy benefit managers (12)
Phase 1 (16244)
Phase 2 (22394)
Phase 3 (15090)
Pipeline (9541)
Policy (38)
Postmarket research (1581)
Preclinical (6868)
Press Release (35)
Prostate cancer (218)
Psychedelics (19)
Radioligand (1)
Radiopharmaceuticals (223)
Rare diseases (713)
Real estate (3289)
Recruiting (10)
Regenerative medicine (19)
Regulatory (15737)
Reports (31)
Research institute (702)
Resumes & cover letters (52)
Rett syndrome (48)
RNA editing (14)
RSV (55)
Saudi Arabia (1)
Schizophrenia (122)
Series A (224)
Series B (153)
Series C (1)
Service/supplier (5)
Sickle cell disease (73)
Special edition (3)
Spinal muscular atrophy (94)
Sponsored (8)
Startups (2307)
Stem cells (3)
Stomach cancer (6)
Substance use disorders (17)
Supply chain (63)
Switzerland (2)
Tariffs (4)
The Weekly (11)
Vaccines (425)
Venture capital (43)
Weight loss (111)
Wet AMD (5)
Women's health (108)
Women in leadership (1)
Worklife (2)
Date
Last 7 days (427)
Last 30 days (2353)
Last 365 days (20062)
2026 (18540)
2025 (20093)
2024 (23715)
2023 (27303)
2022 (35628)
2021 (38311)
2020 (34586)
2019 (24105)
2018 (18215)
2017 (19440)
2016 (18598)
2015 (24897)
2014 (22105)
2013 (18636)
2012 (20721)
2011 (20880)
2010 (20715)
Location
Africa (259)
Alabama (84)
Alaska (2)
Arizona (338)
Arkansas (12)
Asia (19425)
Australia (2342)
California (13889)
Canada (3543)
China (700)
Colorado (566)
Connecticut (483)
Delaware (247)
Europe (27957)
Florida (2030)
Georgia (424)
Hawaii (4)
Idaho (47)
Illinois (837)
India (75)
Indiana (349)
Iowa (19)
Japan (488)
Kansas (117)
Kentucky (36)
Louisiana (32)
Maine (27)
Maryland (1364)
Massachusetts (9125)
Michigan (332)
Minnesota (643)
Mississippi (6)
Missouri (89)
Montana (20)
Nebraska (11)
Nevada (145)
New Hampshire (64)
New Jersey (3043)
New Mexico (13)
New York (3201)
North Carolina (1444)
North Dakota (4)
Northern California (7085)
Ohio (335)
Oklahoma (17)
Oregon (21)
Pennsylvania (2538)
Puerto Rico (26)
Rhode Island (33)
South America (428)
South Carolina (82)
South Dakota (1)
Southern California (5763)
Tennessee (141)
Texas (2290)
United States (44759)
Utah (415)
Vermont (1)
Virginia (178)
Washington D.C. (43)
Washington State (1087)
West Virginia (2)
Wisconsin (101)
Wyoming (1)
504,073 Results for "upstream biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Upstream Bio Reports Third Quarter 2026 Financial Results and Highlights Continued Progress
November 10, 2026
·
10 min read
Press Releases
Upstream Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Progress
August 11, 2026
·
12 min read
Press Releases
Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP
September 1, 2026
·
9 min read
Press Releases
Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences
November 9, 2026
·
10 min read
Job Trends
U.S. bioscience jobs up 7% from 2021 to 2025: Report
Bioscience employment rose in 41 states, though not in California, according to a new report from the Biotechnology Innovation Organization and the Council of State Bioscience Associations.
November 2, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
September 8, 2026
·
8 min read
Press Releases
USP Annual Drug Shortages Report finds rising discontinuations, hidden upstream risk
The average drug shortage now lasts longer than any year on record, more than doubling from 2019.
June 17, 2026
·
2 min read
Press Releases
Upstream Bio to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 3, 2026
·
1 min read
Press Releases
Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026
September 8, 2026
·
10 min read
Press Releases
Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 13, 2026
·
12 min read
1 of 50,408
Next